Ryuji Inoue
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Dynamic remodeling of TRPC5 channel-caveolin-1-eNOS protein assembly potentiates the positive feedback interaction between Ca2+ and NO signals.
Journal: The Journal of biological chemistry
Published: December 08, 2023
The Role of TRPM4 in Cardiac Electrophysiology and Arrhythmogenesis.
Journal: International journal of molecular sciences
Published: June 30, 2023
Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension.
Journal: Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi
Published: August 09, 2022
Theoretical Investigation of the Mechanism by which A Gain-of-Function Mutation of the TRPM4 Channel Causes Conduction Block.
Journal: International journal of molecular sciences
Published: June 25, 2021
An Arrhythmic Mutation E7K Facilitates TRPM4 Channel Activation via Enhanced PIP2 Interaction.
Journal: Cells
Published: March 26, 2021
Pathological activation of CaMKII induces arrhythmogenicity through TRPM4 overactivation.
Journal: Pflugers Archiv : European journal of physiology
Published: September 29, 2020
Substantial involvement of TRPM7 inhibition in the therapeutic effect of Ophiocordyceps sinensis on pulmonary hypertension.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: August 17, 2020
Volume-regulated chloride channel regulates cell proliferation and is involved in the possible interaction between TMEM16A and LRRC8A in human metastatic oral squamous cell carcinoma cells.
Journal: European journal of pharmacology
Published: June 21, 2020
Eicosapentaenoic acid ameliorates pulmonary hypertension via inhibition of tyrosine kinase Fyn.
Journal: Journal of molecular and cellular cardiology
Published: April 22, 2020
Implications of immune-inflammatory responses in smooth muscle dysfunction and disease.
Journal: Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi
Published: February 06, 2020
SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferation.
Journal: Endocrine journal
Published: November 29, 2019
Last Updated: 09/26/2026